Aastrom Biosciences, Inc. (ASTM)
|
1.325
+0.01 (+0.76%)
|
|
|
|
ASTM additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ASTM Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Vanguard Extended Market Idx
iShares Russell Microcap Index
Fidelity Spartan Extended Mkt Index Inv
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Vanguard Balanced Index
USAA Extended Market Index
Fidelity Nasdaq Composite Index Tracking
Fidelity Nasdaq Composite Index
Vantagepoint Broad Market Index I
Vantagepoint Mid/Small Company Index I
iShares Russell Microcap Index
Fidelity Spartan Extended Mkt Index Inv
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Vanguard Balanced Index
USAA Extended Market Index
Fidelity Nasdaq Composite Index Tracking
Fidelity Nasdaq Composite Index
Vantagepoint Broad Market Index I
Vantagepoint Mid/Small Company Index I
•
Competitors
•
Executives
Mr. Timothy M. Mayleben
Chief Exec. Officer
Pres and Director
Mr. Brian D. Gibson
Principal Financial Officer
Chief Accounting Officer VP of Fin. Corp. Sec. and Treasurer
Dr. Ronnda L. Bartel Ph.D.
Chief Scientific Officer
Ms. Sharon M. Watling PharmD
VP of Clinical Devel.
Mr. Dan Orlando r>Chief Commercial Officer
Chief Exec. Officer
Pres and Director
Mr. Brian D. Gibson
Principal Financial Officer
Chief Accounting Officer VP of Fin. Corp. Sec. and Treasurer
Dr. Ronnda L. Bartel Ph.D.
Chief Scientific Officer
Ms. Sharon M. Watling PharmD
VP of Clinical Devel.
Mr. Dan Orlando r>Chief Commercial Officer
•
Employee Count
71
Special Offers
Competitors
ASTM earnings
Date
Actual
Expected
Prev Yr Qtr
11/8/2012
-0.17
-0.23
-0.05
8/7/2012
-0.22
-0.24
-0.26
5/10/2012
-0.25
-0.20
-0.13
